Expression of bcl-2 by breast cancer: A possible diagnostic application

Modern Pathology

Volumn 9, Issue 4, 1996, Pages 439-444

  Alsabeh, Randa ^a   Wilson, Carla S ^a   Ahn, Chul W ^a   Vasef, Mohammad A ^a   Battifora, Hector ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

bcl 2; Breast cancer; Immunohistochemistry; Metastases; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; GENES, BCL-2; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029974539     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wilson C, Vasef M, Battifora H: Overexpression of bcl-2 by breast cancer. Possible diagnostic applications (abstract). Mod Pathol 8:28A, 1995
2. Tsujimoto Y, Cossman J, Jaffe E, Croce C: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440, 1985
3. Bakhshi A, Jenser JP, Goldman P, et al: Cloning of the chromosome breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899, 1985
4. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19, 1986
5. Hockenberry D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
6. Pezzella F, Tse AG, Cordell JL, et al: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225, 1990
7. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ: bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301, 1994
8. Nathan B, Anbazhagan R, Clarkson P, Bartkova J, Gusterson B: Expression of bcl-2 in the developing human fetal and infant breast. Histopathology 24:73, 1994
9. Lu Q-L, Poulsom R, Wong L, Hanby AM: bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431, 1993
10. LeBrun DP, Warnke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743, 1993
11. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961, 1991
12. Gompel A, Sabourin JC, Martin A, et al.: bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144:1195, 1994
13. Otsuki Y, Misaki O, Sugimoto O, et al.: Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 344:28, 1994
14. Pilotti S, Collini P, Rilke F, et al.: bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337, 1994
15. Charlotte F, L'Herminé A, Martin N, et al: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 144:460, 1994
16. Van den Oord JJ, Vandeghinste N, De Ley M, De Wolf-Peeters C: bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 145:294, 1994
17. McDonnell TJ, Troncoso P, Brisbay SM: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940, 1992
18. Segal NH, Cohen RJ, Haffejee Z, Savage N: bcl-2 protooncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell. Arch Pathol Lab Med 118:616, 1994
19. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y: Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 54:6, 1994
20. Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G: Small cell carcinomas of the lung express the bcl-2 protein. Am J Pathol 145:1036, 1995
21. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135, 1994
22. Bhargava V, Kell DL, van de Rijn M, Warnke RA: bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535, 1994
23. Pezzella F, Turley H, Kuzu I, et al.: bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 329:690, 1993
24. Korsmeyer SJ: bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
25. Silvestrini R, Veneroni S, Daidone MG, et al: The bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499, 1994
26. Gaffney EF, O'Neill AJ, Staunton MJ: bcl-2 and prognosis in non-small-cell lung carcinoma. N Engl J Med 159:1757, 1994
27. Le Doussal V, Tubiana-Hulin M, Friedman S, et al.: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64:1914, 1989
28. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19:403, 1991
29. Kandalaft PL, Chang KL, Ahn CW, et al.: Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer 71:2756, 1993
30. Battifora H, Gaffey M, Esteban JM, et al: Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer. Retrospective follow-up study of 245 stage I and II cases. Mod Pathol 4:466, 1991
31. Gown AM, De Wever N, Battifora H: Microwave-based antigenic unmasking: A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1:256, 1993
32. Lauwers GY, Scott GV, Karpeh MS: Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 75:2209, 1995
33. Ayhan A, Yasui W, Yokozaki H, et al.: Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 85:584, 1995
34. Esteban JM, Battifora H: Tumor immunophenotype: Comparison between primary neoplasm and its metastases. Mod Pathol 3:192, 1990
35. Wick MR, Lillemoe TJ, Copland GT, et al.: Gross cystic disease fluid protein-15 as a marker for breast cancer: Immunohistochemical analysis of 690 human neoplasms and comparison with α-lactalbumin. Hum Pathol 20:281, 1989
36. Mazoujian G, Bodian C, Haagensen DE, Haagensen CD: Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 63:2156, 1989
37. Lee AK, Tallberg K, DeLellis RA, et al.: α-lactalbumin as an immunohistochemical marker for metastatic breast carcinomas. Am J Surg Pathol 8:93, 1984
38. Castagna M, Viacava P, Turchi V, et al: Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody. Pathol Res Pract 188:1002, 1992
39. Beketic-Oreskovic L, Sarcevic B, Malenica B, Novak D: Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma. Neoplasma 40:69, 1993
40. Cardoso de Almeida PC, Pestana CB: Immunohistochemical markers in the identification of metastatic breast cancer. Breast Cancer Res Treat 21:201, 1992
41. Deamant FD, Pombo MT, Battifora H: Estrogen receptor immunohistochemistry as a predictor of breast origin in metastatic cancer. Appl Immunohistochem 1:188, 1993
42. Akasofu M, Kawahara E, Kurumaya H, Nakanishi I: Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver. Acta Pathol Jpn 43:736, 1993
43. Raab SS, Berg LC, Swanson PE, Wick MR: Adenocarcinoma in the lung in patients with breast cancer: A prospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol 100:27, 1993